Suke Deng
Impact in
-
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
-
- Immune cells in cancer 5
- Immunotherapy and Immune Responses 4
- Immune Cell Function and Interaction 2
-
- Extracellular vesicles in disease 2
- Epigenetics and DNA Methylation 2
- Co-authors
- Kunyu Yang (11 shared papers)Jingshu Meng (7 shared papers)Yan Hu (5 shared papers)Honglin Jin (4 shared papers)Jonathan F. Lovell (3 shared papers)Chao Wan (10 shared papers)Jing Huang (3 shared papers)Xiaomeng Dai (2 shared papers)
- Journals
- Theranostics (3 papers)Cancer Letters (1 paper)Cell Reports Medicine (1 paper)Frontiers in Bioengineering and Biotechnology (1 paper)OncoImmunology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Suke Deng
11 papers receiving 407 citations
Hit Papers
Peers
Comparison fields: 5 of 61
- Immunology 147
- Cancer Research 77
- Oncology 124
- Molecular Medicine 17
- Biomaterials 42
Countries citing papers authored by Suke Deng
This map shows the geographic impact of Suke Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suke Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suke Deng more than expected).
Fields of papers citing papers by Suke Deng
This network shows the impact of papers produced by Suke Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suke Deng. The network helps show where Suke Deng may publish in the future.
Co-authors
The 25 scholars most cited alongside Suke Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 195 | |
| 2 | 2020 | 76 | |
| 3 | Ferroptosis‐Enhanced Immunotherapy with an Injectable Dextran‐Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular Carcinoma Hit paper breakdown → | 2023 | 71 |
| 4 | 2024 | 23 | |
| 5 | 2024 | 14 | |
| 6 | 2023 | 9 | |
| 7 | 2024 | 8 | |
| 8 | 2023 | 6 | |
| 9 | 2024 | 3 | |
| 10 | 2023 | 2 | |
| 11 | 2024 | 2 |
About Suke Deng
Suke Deng is a scholar working on Immunology, Molecular Biology, Oncology, Cancer Research and Biomedical Engineering, having authored 11 papers that have together received 409 indexed citations. Recurring topics across this work include Immune cells in cancer (5 papers), Immunotherapy and Immune Responses (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Nanoplatforms for cancer theranostics (2 papers), Extracellular vesicles in disease (2 papers), Epigenetics and DNA Methylation (2 papers), Immune Cell Function and Interaction (2 papers) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Immunology (147 citations), Cancer Research (77 citations), Oncology (124 citations), Molecular Medicine (17 citations) and Biomaterials (42 citations). Suke Deng has collaborated with scholars based in China and United States. Frequent co-authors include Kunyu Yang, Jingshu Meng, Yan Hu, Honglin Jin, Jonathan F. Lovell, Chao Wan, Jing Huang, Xiaomeng Dai, Lisen Lu and Gang Wu. Their work appears in journals such as Theranostics, Cancer Letters, Cell Reports Medicine, Frontiers in Bioengineering and Biotechnology and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.